89 related articles for article (PubMed ID: 12854363)
1. Toxicity and pharmacokinetics of stampidine in mice and rats.
Uckun FM; Chen CL; Lisowski E; Mitcheltree GC; Venkatachalam TK; Erbeck D; Chen H; Waurzyniak B
Arzneimittelforschung; 2003; 53(5):357-67. PubMed ID: 12854363
[TBL] [Abstract][Full Text] [Related]
2. In vivo pharmacokinetics and toxicity profile of the anti-HIV agent stampidine in dogs and feline immunodeficiency virus-infected cats.
Uckun FM; Waurzyniak B; Tibbles H; Venkatachalam TK; Erbeck D
Arzneimittelforschung; 2006 Feb; 56(2A):176-92. PubMed ID: 16570826
[TBL] [Abstract][Full Text] [Related]
3. In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice.
Uckun FM; Qazi S; Pendergrass S; Lisowski E; Waurzyniak B; Chen CL; Venkatachalam TK
Antimicrob Agents Chemother; 2002 Nov; 46(11):3428-36. PubMed ID: 12384347
[TBL] [Abstract][Full Text] [Related]
4. Stampidine as a novel nucleoside reverse transcriptase inhibit with potent anti-HIV activity.
Uckun FM
Arzneimittelforschung; 2006 Feb; 56(2A):121-35. PubMed ID: 16570821
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of stavudine-5'-[p-bromophenyl methoxyalaninyl phosphate], stampidine, in mice, dogs, and cats.
Chen CL; Yu G; Venkatachalam TK; Uckun FM
Drug Metab Dispos; 2002 Dec; 30(12):1523-31. PubMed ID: 12433828
[TBL] [Abstract][Full Text] [Related]
6. Developmental safety profile of the anti-HIV agent stampidine in rabbits.
D'Cruz OJ; Erbeck D; Uckun FM
Arzneimittelforschung; 2006 Feb; 56(2A):159-66. PubMed ID: 16570824
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a thermoreversible ovule formulation of stampidine, a novel nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicide.
D'Cruz OJ; Samuel P; Waurzyniak B; Uckun FM
Biol Reprod; 2003 Dec; 69(6):1843-51. PubMed ID: 12890726
[TBL] [Abstract][Full Text] [Related]
8. Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDS.
Uckun FM; Cahn P; Qazi S; D'Cruz O
Expert Opin Investig Drugs; 2012 Apr; 21(4):489-500. PubMed ID: 22360744
[TBL] [Abstract][Full Text] [Related]
9. In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs.
Uckun FM; Qazi S; Venkatachalam TK
Arzneimittelforschung; 2005; 55(4):223-31. PubMed ID: 15901046
[TBL] [Abstract][Full Text] [Related]
10. Stampidine is a potential nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicide.
D'Cruz OJ; Uckun FM
Fertil Steril; 2004 Mar; 81 Suppl 1():831-41. PubMed ID: 15019817
[TBL] [Abstract][Full Text] [Related]
11. Potency of stampidine against multi-nucleoside reverse transcriptase inhibitor resistant human immunodeficiency viruses.
Uckun FM; Venkatachalam TK; Qazi S
Arzneimittelforschung; 2006 Feb; 56(2A):193-203. PubMed ID: 16570827
[TBL] [Abstract][Full Text] [Related]
12. In vivo antiretroviral activity of stampidine in chronically feline immunodeficiency virus-infected cats.
Uckun FM; Chen CL; Samuel P; Pendergrass S; Venkatachalam TK; Waurzyniak B; Qazi S
Antimicrob Agents Chemother; 2003 Apr; 47(4):1233-40. PubMed ID: 12654652
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates.
Uckun FM; Pendergrass S; Qazi S; Venkatachalam TK
Arzneimittelforschung; 2004; 54(1):69-77. PubMed ID: 14979612
[TBL] [Abstract][Full Text] [Related]
14. Anti-retroviral activity of GMP-grade stampidine against genotypically and phenotypically nucleoside reverse transcriptase inhibitor resistant recombinant human immunodeficiency virus. An in vitro study.
Uckun FM; DuMez D; Qazi S; Tibbles H; Venkatachalam TK
Arzneimittelforschung; 2007; 57(2):112-21. PubMed ID: 17396622
[TBL] [Abstract][Full Text] [Related]
15. Stampidine: a selective oculo-genital microbicide.
D'Cruz OJ; Uckun FM
J Antimicrob Chemother; 2005 Jul; 56(1):10-9. PubMed ID: 15919769
[TBL] [Abstract][Full Text] [Related]
16. In vivo pharmacokinetics and metabolism of anti-human immunodeficiency virus agent D4T-5'-[p-bromophenyl methoxyalaninyl phosphate] (SAMPIDINE) in mice.
Chen CL; Venkatachalam TK; Zhu ZH; Uckun FM
Drug Metab Dispos; 2001 Jul; 29(7):1035-41. PubMed ID: 11408371
[TBL] [Abstract][Full Text] [Related]
17. Unmet challenges in HIV therapy and potential of stampidine.
Uckun FM
Arzneimittelforschung; 2006 Feb; 56(2A):117-20. PubMed ID: 16570820
[No Abstract] [Full Text] [Related]
18. Large-scale synthesis and formulation of GMP-grade stampidine, a new anti-HIV agent.
DuMez D; Venkatachalam TK; Uckun FM
Arzneimittelforschung; 2006 Feb; 56(2A):136-51. PubMed ID: 16570822
[TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacokinetics, metabolism, toxicity, and anti-HIV activity of N'-[2-(2-Thiophene)ethyl]-N'-[2-(5-bromopyridyl)]thiourea (HI-443), a potent non-nucleoside inhibitor of HIV reverse transcriptase.
Uckun FM; Tibbles HE; Venkatachalam TK; Erbeck D
Arzneimittelforschung; 2007; 57(7):483-96. PubMed ID: 17803063
[TBL] [Abstract][Full Text] [Related]
20. Lipase-mediated stereoselective hydrolysis of stampidine and other phosphoramidate derivatives of stavudine.
Venkatachalam TK; Samuel P; Li G; Qazi S; Mao C; Pendergrass S; Uckun FM
Bioorg Med Chem; 2004 Jun; 12(12):3371-81. PubMed ID: 15158806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
